Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2015-06-09 16:03:27 |
Versijas komentārs | |
Teksts |
Olainfarm holds
First Quarter 2015 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its first quarter 2015 investor
conference webinar scheduled on June 9, 2015 at 16:00 (EET).
Please note that attendees have to register for the webinar
– detailed information on the registration process is available
below. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities
and analyze the non-audited financial results of the first quarter
2015 and audited financial results of 2014. After the presentation
investors are welcome to ask questions. During the webinar the
enclosed presentation will be presented.
How to join the
webinar? To join the webinar, we invite you
to register via
http://ej.uz/OLF_1Q2015. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. For more
information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/ JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia Information
prepared by: |
Pielikumi |